U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06992713) titled 'A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors' on May 09.
Brief Summary: This is a phase Ia clinical study evaluating H1710 for Injection in Participants with advanced solid tumors.
Study Start Date: May 28
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumor
Intervention:
DRUG: H1710 for Injection
Injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....